FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
BofA Securities analyst Tim Anderson raised the price target on Gilead Sciences (NASDAQ: GILD) to $162.00 (from $154.00) while maintaining a Buy rating.
The analyst comments "GILD reported strong 4Q product revenues of $7.9bn ahead of Street estimates (BofA: +4%, cons: +4%) driven by demand outperformance from... More

